Donor-Derived Epstein-Barr Virus Infection Increases the Risk for Posttransplant Lymphoproliferative Disorder by 5- to 10-Fold Higher Than Previous Estimates Among Kidney Transplant Recipients

A retrospective cohort study aimed to determine the associations between pre-transplant Epstein-Barr virus (EBV)-seronegative recipients of EBV-seropositive donor (EBV D+ /R-) and recipient EBV-seropositive status (R+) and incidence of posttransplant lymphoproliferative disorder (PTLD) among adult kidney transplant recipients. 

Read More